A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants
PHASE1
The purpose of the study is to assess the tolerability, safety, and pharmac...
Retrospective, Observational Chart Review Study Conducted in Poland to Document the Management and Clinical Outcome of CUVITRU and HYQVIA in Pediatric Participants (< 18 Years) With Primary Immunodeficiency (PID)
N/A
The purpose of this observational, multi-center, retrospective cohort study...
Status
Completed
Location
Uniwersyteckie Centrum Kliniczne
Start Date
2021-02-08
Trial ID
NCT04636502
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
N/A
The main aims of this study are to understand why adults with Chronic Infla...